Management of Immunocompetent Patient with Positive Serum Cryptococcal Antigen
Initial Evaluation
- A positive serum cryptococcal antigen implies deep tissue invasion and a high likelihood of disseminated disease, even in immunocompetent patients 3, 4
- Lumbar puncture should be performed to rule out CNS involvement, as the organism has a strong predilection for infecting the CNS 3, 5
- If CNS symptoms are absent and serum cryptococcal antigen titer is low, some experts support not performing a lumbar puncture 2
- Complete evaluation should include a chest radiograph to identify pulmonary involvement 6, blood cultures to rule out cryptococcemia 1, and assessment for symptoms of dissemination to other sites 1
Treatment Algorithm
- For single-site infection without fungemia and no immunosuppressive risk factors, the Infectious Diseases Society of America recommends fluconazole 400 mg (6 mg/kg) daily orally for 6-12 months 1, 4
- Alternative: Itraconazole 200-400 mg daily for 6-12 months if fluconazole is not an option 4, 7
- Treat as CNS disease if any of the following are present: involvement of at least 2 noncontiguous sites 2, evidence of high fungal burden (cryptococcal antigen titer ≥1:512) 1, or positive blood cultures for Cryptococcus 1, 2
Special Considerations
- For patients with severe symptoms or ARDS, consider amphotericin B with or without flucytosine as initial therapy 5, 8
- Surgical resection may be considered for patients with persistent focal radiographic abnormalities despite conventional antifungal therapy 2, 5
Monitoring and Follow-up
- Treatment duration should be based on resolution of disease 4
- For persistent symptoms or signs, consider surgical resection of focal pulmonary disease rather than continuing long-term antifungal therapy 2